Literature DB >> 31926850

Blood lipid profiles and risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies.

Bo Guan1, Xintao Li2, Wenqiang Xue3, Gary Tse3, Khalid Bin Waleed3, Yichen Liu4, Mengyi Zheng5, Shouling Wu5, Yunlong Xia6, Yi Ding7.   

Abstract

BACKGROUND: There is an increasing body of evidence associating traditional cardiovascular risk factors with atrial fibrillation (AF), but the relationship between blood lipid profiles and the risk of AF remains controversial.
OBJECTIVE: This study aimed to conduct a systemic review and meta-analysis of large cohort studies to evaluate the relationship between blood lipid profiles and incident AF.
METHODS: PubMed and Embase were searched up to January 31, 2019, for cohort studies that reported the relationship between blood lipid levels and incident AF. The hazard ratios or odds ratios of the highest vs lowest categories of lipid levels were extracted to calculate pooled estimates. Sensitivity analysis and meta-regression were performed to explore potential sources of heterogeneity.
RESULTS: Eleven studies were included in the meta-analysis, including 9 studies for total cholesterol (TC), 5 for low-density lipoprotein cholesterol (LDL-C), 8 for high-density lipoprotein cholesterol (HDL-C), and 8 for triglyceride. Serum TC and LDL-C levels were inversely related to AF risk (relative risk [RR] = 0.81, 95% confidence interval [CI]: 0.72-0.92; RR = 0.79, 95% CI: 0.70-0.88, respectively). Likewise, elevated HDL-C levels were associated with a reduced AF risk (RR = 0.86, 95% CI: 0.76-0.97), whereas no significant association was observed between triglyceride levels and incident AF (RR = 1.02, 95% CI: 0.90-1.17).
CONCLUSIONS: Our meta-analysis of large cohort studies found an inverse relationship between serum TC, LDL-C, and HDL-C levels and AF risk, although there was no significant association between TG levels and incident AF. Future studies regarding AF risk stratification may take these blood lipids into consideration, and further efforts are needed to investigate the potential mechanisms.
Copyright © 2020 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Epidemiology; Lipids; Risk factors

Mesh:

Substances:

Year:  2019        PMID: 31926850     DOI: 10.1016/j.jacl.2019.12.002

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  12 in total

1.  Association between serum apolipoprotein B and atrial fibrillation: a case-control study.

Authors:  Xia Zhong; Huachen Jiao; Dongsheng Zhao; Jing Teng
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

2.  A case-control study to investigate association between serum uric acid levels and paroxysmal atrial fibrillation.

Authors:  Xia Zhong; Huachen Jiao; Dongsheng Zhao; Jing Teng
Journal:  Sci Rep       Date:  2022-06-20       Impact factor: 4.996

3.  Early pharmacologic conversion of atrial fibrillation after off-pump coronary artery bypass grafting.

Authors:  Heemoon Lee; Hee Jung Kim; Jae Suk Yoo; Dong Jin Kim; Sang Youn Yeom; Kwang Ree Cho
Journal:  J Thorac Dis       Date:  2021-07       Impact factor: 2.895

4.  Biochemical predictors of postoperative atrial fibrillation following cardiac surgery.

Authors:  Sevket T Turkkolu; Emre Selçuk; Cengiz Köksal
Journal:  BMC Cardiovasc Disord       Date:  2021-04-09       Impact factor: 2.298

5.  The Relationship between Blood Lipids and Risk of Atrial Fibrillation: Univariable and Multivariable Mendelian Randomization Analysis.

Authors:  Shengyi Yang; Rupak Pudasaini; Hong Zhi; Lina Wang
Journal:  Nutrients       Date:  2021-12-31       Impact factor: 5.717

6.  Enhancing Fatty Acids Oxidation via L-Carnitine Attenuates Obesity-Related Atrial Fibrillation and Structural Remodeling by Activating AMPK Signaling and Alleviating Cardiac Lipotoxicity.

Authors:  Yudi Zhang; Yuping Fu; Tiannan Jiang; Binghua Liu; Hongke Sun; Ying Zhang; Boyuan Fan; Xiaoli Li; Xinghua Qin; Qiangsun Zheng
Journal:  Front Pharmacol       Date:  2021-11-26       Impact factor: 5.810

7.  Relationship between serum lipid levels and ischemic stroke in patients with atrial fibrillation: a nested case-control study based on the China Atrial Fibrillation Registry.

Authors:  Fei Li; Xin Du; Liu He; Chao Jiang; Shijun Xia; Changsheng Ma; Jianzeng Dong
Journal:  BMC Cardiovasc Disord       Date:  2021-09-08       Impact factor: 2.298

8.  Association of Lipoprotein (a) variants with risk of cardiovascular disease: a Mendelian randomization study.

Authors:  Juan Xia; Chunyue Guo; Kuo Liu; Yunyi Xie; Han Cao; Wenjuan Peng; Yanyan Sun; Xiaohui Liu; Bingxiao Li; Ling Zhang
Journal:  Lipids Health Dis       Date:  2021-06-01       Impact factor: 3.876

Review 9.  Relationship between lipoproteins, thrombosis, and atrial fibrillation.

Authors:  Wern Yew Ding; Majd B Protty; Ian G Davies; Gregory Y H Lip
Journal:  Cardiovasc Res       Date:  2022-02-21       Impact factor: 10.787

10.  Lp(a) (Lipoprotein [a]) and Risk for Incident Atrial Fibrillation: Multi-Ethnic Study of Atherosclerosis.

Authors:  Parveen K Garg; Weihua Guan; Amy B Karger; Brian T Steffen; Wesley O'Neal; Susan R Heckbert; Erin D Michos; Michael Y Tsai
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.